{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:06:57Z","timestamp":1791821217701,"version":"4.3.4"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2304605, 2022YFC2304604"],"award-info":[{"award-number":["2022YFC2304605, 2022YFC2304604"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Ventilator-associated pneumonia (VAP) carries a high mortality rate in the intensive care units (ICUs) due to its widespread drug resistance. Traditional microbial cultures limited by speed and sensitivity, are often unable to help clinicians make effective diagnosis and treatment. Therefore, there is an urgent need for a rapid and accurate test that can identify both pathogens and their antimicrobial resistance (AMR) to improve the prognosis of patients with VAP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study design<\/jats:title><jats:p>We analyzed samples from ICU patients with suspected VAP using both microbial tests and targeted next-generation sequencing (tNGS), comparing the results of tNGS pathogen and AMR detection against microbial culture and antimicrobial susceptibility testing (AST).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Involving 199 patients with suspected VAP, tNGS showed a sensitivity rate of 98.98% for pathogen identification. While the sensitivity rate of microbial culture was just 66.84%. Additionally, tNGS performed almost half the turnaround time of microbial culture (1.66 days vs 3.00 days). For AMR, the overall consistency between AST and tNGS was 79.31%. The great performance particularly exhibited for <jats:italic>Acinetobacter baumannii<\/jats:italic> carbapenem-penicillin-cephamycin resistance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>tNGS excels in identifying pathogens and AMR. Its rapid workflow makes it ideal for managing critically ill patients, enhancing treatment precision, and reducing antibiotic misuse.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2025.1526087","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:40:34Z","timestamp":1738305634000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Targeted next-generation sequencing for antimicrobial resistance detection in ventilator-associated pneumonia"],"prefix":"10.3389","volume":"15","author":[{"given":"Yuting","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejian","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41564-018-0349-6","article-title":"Analytical and clinical validation of A microbial cell-free dna sequencing test for infectious disease","volume":"4","author":"Blauwkamp","year":"2019","journal-title":"Nat. Microbiol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13010002","article-title":"Estimation of additional costs in patients with ventilator-associated pneumonia","volume":"13","author":"Cabrera-Tejada","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2024.13277","article-title":"Clinical diagnostic value of targeted next\u2212Generation sequencing for infectious diseases (Review)","volume":"30","author":"Chen","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41576-019-0113-7","article-title":"Clinical metagenomics","volume":"20","author":"Chiu","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"B5","article-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2022","journal-title":"CLSI document M100."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.ajic.2019.02.030","article-title":"Multidrug-resistant pseudomonas aeruginosa and mortality in mechanically ventilated icu patients","volume":"47","author":"Denis","year":"2019","journal-title":"Am. J. Infect. Control"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11133764","article-title":"Frequency, etiology, mortality, cost, and prevention of respiratory tract infections-prospective, one center study","volume":"11","author":"Duszynska","year":"2022","journal-title":"J. Clin. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1128\/JCM.00472-13","article-title":"Can molecular methods detect 1% Isoniazid resistance in mycobacterium tuberculosis","volume":"51","author":"Folkvardsen","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1128\/JCM.01602-13","article-title":"Rifampin heteroresistance in mycobacterium tuberculosis cultures as detected by phenotypic and genotypic drug susceptibility test methods","volume":"51","author":"Folkvardsen","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12941-024-00690-7","article-title":"Antimicrobial resistance prediction by clinical metagenomics in pediatric severe pneumonia patients","volume":"23","author":"Gan","year":"2024","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00526-22","article-title":"Evaluation of metagenomic and targeted next-generation sequencing workflows for detection of respiratory pathogens from bronchoalveolar lavage fluid specimens","volume":"60","author":"Gaston","year":"2022","journal-title":"J. Clin. Microbiol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1181348","article-title":"Multiplex pcr-based next generation sequencing as A novel, targeted and accurate molecular approach for periprosthetic joint infection diagnosis","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Microbiol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1303456","article-title":"Epidemiological investigation of lower respiratory tract infections during influenza A (H1n1) pdm09 virus pandemic based on targeted next-generation sequencing","volume":"13","author":"Li","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jinf.2022.08.022","article-title":"Targeted next generation sequencing is comparable with metagenomic next generation sequencing in adults with pneumonia for pathogenic microorganism detection","volume":"85","author":"Li","year":"2022","journal-title":"J. Infect."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001771","article-title":"Performance of targeted next-generation sequencing in the detection of respiratory pathogens and antimicrobial resistance genes for children","volume":"72","author":"Lin","year":"2023","journal-title":"J. Med. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jinf.2021.01.029","article-title":"Metagenomic next-generation sequencing for the diagnosis of suspected pneumonia in immunocompromised patients","volume":"82","author":"Peng","year":"2021","journal-title":"J. Infect."},{"key":"B17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.cmi.2021.09.039","article-title":"Culture-independent detection systems for bloodstream infection","volume":"28","author":"Peri","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"B18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/ijp.ijp_759_21","article-title":"A clinical study on the pattern of antimicrobial drug use and drug resistance in patients with ventilator-associated pneumonia in A tertiary care hospital","volume":"55","author":"Rezia","year":"2023","journal-title":"Indian J. Pharmacol."},{"key":"B19","first-page":"339","article-title":"Heteroresistance in mycobacterium tuberculosis","volume":"5","author":"Rinder","year":"2001","journal-title":"Int. J. Tuberc Lung Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12257-020-0342-9","article-title":"Dna microarray-based detection of bacteria in samples containing antibiotics: effect of antibiotics on the performance of pathogen detection assays","volume":"26","author":"Shin","year":"2021","journal-title":"Biotechnol. And Bioprocess Eng."},{"key":"B21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jhin.2021.02.026","article-title":"Impact of healthcare-associated infection on length of stay","volume":"114","author":"Stewart","year":"2021","journal-title":"J. Hosp Infect."},{"key":"B22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1164\/rccm.202202-0357OC","article-title":"Attributable mortality of ventilator-associated pneumonia among patients with covid-19","volume":"206","author":"Vacheron","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041298","article-title":"Ventilator-associated pneumonia in covid-19 patients admitted in intensive care units: relapse, therapeutic failure and attributable mortality-A multicentric observational study from the outcomerea network","volume":"12","author":"Wicky","year":"2023","journal-title":"J. Clin. Med."},{"key":"B24","year":"2024","journal-title":"WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance"},{"key":"B25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jinf.2023.01.031","article-title":"Application of targeted next generation sequencing technology in the diagnosis of mycobacterium tuberculosis and first line drugs resistance directly from cell-free dna of bronchoalveolar lavage fluid","volume":"86","author":"Wu","year":"2023","journal-title":"J. Infect."},{"key":"B26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/pathogens3020437","article-title":"Wgs analysis and interpretation in clinical and public health microbiology laboratories: what are the requirements and how do existing tools compare","volume":"3","author":"Wyres","year":"2014","journal-title":"Pathogens"},{"key":"B27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13054-024-05009-8","article-title":"Clinical application of targeted next-generation sequencing in severe pneumonia: A retrospective review","volume":"28","author":"Zhang","year":"2024","journal-title":"Crit. Care"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1526087\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:40:36Z","timestamp":1738305636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1526087\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":27,"alternative-id":["10.3389\/fcimb.2025.1526087"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1526087","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"article-number":"1526087"}}